Stephen Juraschek

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Stephen Juraschek sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Stephen Juraschek: 1 sponsored US clinical trial, 1 recruiting.

Stephen Juraschek sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Controlled Hypertension, with 1 trials.

Mid-pack sponsor footprint

Stephen Juraschek is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING NA

Wearable Evaluation of Ambulatory Readings for Blood Pressure

NCT06610448

Therapeutic Areas

Controlled Hypertension 1
Normal Blood Pressure 1
Uncontrolled Hypertension 1

What is open in the Stephen Juraschek pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Controlled Hypertension (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Stephen Juraschek: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Stephen Juraschek sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share Stephen Juraschek1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Stephen Juraschek sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Stephen Juraschek sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Stephen Juraschek page

1 registered trials is a research-attention snapshot, not an endorsement of Stephen Juraschek or any single study.

  • 1 of Stephen Juraschek's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Controlled Hypertension is the condition Stephen Juraschek studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Controlled Hypertension trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Stephen Juraschek pipeline card: 1 registered trials from official public datasets.Report a data error.